Lyell Immunopharma has reported new clinical data from the Phase I/II clinical trial of CAR T-cell product candidate, LYL314.

Industry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence ...

Streeting has also promised to reduce the time it takes to get clinical trials approved by cutting red tape, pointing out ...

Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...

Federal research funding cuts pose an “existential threat” to academic medicine that will have repercussions for patient care ...

An often cited example of the importance of including a wide sample of patients is research showing that certain drugs can be ...

(100%) in the 180mg cohort achieved a clinical response Tryptase levels below the lower limit of quantification observed in ...

Independent report confirms Ambience Healthcare’s AI platform reduces clinician burnout, enhances patient care, and ...

In response to the proposal presented by Zydus Healthcare, the Subject Expert Committee (SEC) functional under the Central ...

In this video interview, Matt Robinson, PhD, senior director, oncology research program, National Comprehensive Cancer ...

and one of the most crucial is the Clinical Study Report (CSR). It details the results, methodology, and analysis of the trial, providing regulators with a transparent look into the safety ...